
Edita Mištinienė
businessFemale0.0Global Dominance: 0.00%
Edita Mištinienė is the CEO of the company Profarma, which was involved in a controversial procurement of rapid COVID-19 tests, facing scrutiny over allegations of irregularities in the bidding process and overcharging the state.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Edita Mištinienė is the head of the company 'Profarma' involved in the procurement case.
Greitųjų COVID-19 testų pirkimo byloje teismas apklaus Saulių Skvernelį15min – major Lithuanian news website·
Lithuania· 2025-06-17




